Filing Details

Accession Number:
0000950170-24-070605
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-07 16:05:19
Reporting Period:
2024-06-05
Accepted Time:
2024-06-07 16:05:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1720580 Adicet Bio Inc. ACET () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1364719 Michael Kauffman C/O Adicet Bio, Inc.
131 Dartmouth Street, Floor 3
Boston MA 02116
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-05 5,900 $0.00 11,800 No 4 A Direct
Common Stock Disposition 2024-06-05 5,900 $1.43 5,900 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2024-06-05 26,400 $0.00 26,400 $1.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,400 2034-06-04 No 4 A Direct
Footnotes
  1. The Reporting Person was issued Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors. The RSUs may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.
  2. These shares shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors.